Cargando…
ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective
Maturity-onset diabetes of the young (MODY) is a heterogeneous group of diseases associated with gene mutations leading to dysfunction of pancreatic β-cells. Thirteen identified MODY variants differ from each other by the clinical course and treatment requirement. Currently, MODY subtypes 1–5 are be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014798/ https://www.ncbi.nlm.nih.gov/pubmed/27538677 http://dx.doi.org/10.1007/s13300-016-0192-9 |
_version_ | 1782452329897787392 |
---|---|
author | Ovsyannikova, Alla K. Rymar, Oksana D. Shakhtshneider, Elena V. Klimontov, Vadim V. Koroleva, Elena A. Myakina, Natalya E. Voevoda, Mikhail I. |
author_facet | Ovsyannikova, Alla K. Rymar, Oksana D. Shakhtshneider, Elena V. Klimontov, Vadim V. Koroleva, Elena A. Myakina, Natalya E. Voevoda, Mikhail I. |
author_sort | Ovsyannikova, Alla K. |
collection | PubMed |
description | Maturity-onset diabetes of the young (MODY) is a heterogeneous group of diseases associated with gene mutations leading to dysfunction of pancreatic β-cells. Thirteen identified MODY variants differ from each other by the clinical course and treatment requirement. Currently, MODY subtypes 1–5 are best-studied, descriptions of the other forms are sporadic. This article reports a MODY12 clinical case, caused by a mutation in the gene of the ATP-binding cassette transporter sub-family C member 8 (ABCC8), encoding sulfonylurea receptor 1. Diabetes manifested in a 27-year-old non-obese man with epilepsy in anamnesis. No evidence of ketosis was present, pancreatic antibodies were undetectable, and C-peptide remained within the reference range. During the initial investigation, non-proliferative diabetic retinopathy and elevated albumin excretion rate was revealed. After 4 months, diabetes was complicated by pre-proliferative retinopathy and diabetic macular edema. Recurrent hypoglycemia and an increase in body weight was observed on moderate and even small insulin doses. Taking into account the clinical features and the presence of diabetes in four generations on the maternal side, screening for all MODY subtypes was performed. A mutation in the ABCC8 gene was found in proband and in his mother. After the insulin discontinuation, gliclazide modified release combined with sodium/glucose cotransporter 2 (SGLT2) inhibitors was started. This treatment eliminated hypoglycemia and improved glycemic variability parameters. A decrease in the amplitude of glucose excursions was documented by continuous glucose monitoring. After 3 months of treatment, glycemic control was still optimal, and no hypoglycemic episodes were observed. The case report demonstrates the clinical features of ABCC8-associated MODY and the therapeutic potential of a combination of sulfonylurea with SGLT2 inhibitor in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13300-016-0192-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5014798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-50147982016-09-19 ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective Ovsyannikova, Alla K. Rymar, Oksana D. Shakhtshneider, Elena V. Klimontov, Vadim V. Koroleva, Elena A. Myakina, Natalya E. Voevoda, Mikhail I. Diabetes Ther Case Report Maturity-onset diabetes of the young (MODY) is a heterogeneous group of diseases associated with gene mutations leading to dysfunction of pancreatic β-cells. Thirteen identified MODY variants differ from each other by the clinical course and treatment requirement. Currently, MODY subtypes 1–5 are best-studied, descriptions of the other forms are sporadic. This article reports a MODY12 clinical case, caused by a mutation in the gene of the ATP-binding cassette transporter sub-family C member 8 (ABCC8), encoding sulfonylurea receptor 1. Diabetes manifested in a 27-year-old non-obese man with epilepsy in anamnesis. No evidence of ketosis was present, pancreatic antibodies were undetectable, and C-peptide remained within the reference range. During the initial investigation, non-proliferative diabetic retinopathy and elevated albumin excretion rate was revealed. After 4 months, diabetes was complicated by pre-proliferative retinopathy and diabetic macular edema. Recurrent hypoglycemia and an increase in body weight was observed on moderate and even small insulin doses. Taking into account the clinical features and the presence of diabetes in four generations on the maternal side, screening for all MODY subtypes was performed. A mutation in the ABCC8 gene was found in proband and in his mother. After the insulin discontinuation, gliclazide modified release combined with sodium/glucose cotransporter 2 (SGLT2) inhibitors was started. This treatment eliminated hypoglycemia and improved glycemic variability parameters. A decrease in the amplitude of glucose excursions was documented by continuous glucose monitoring. After 3 months of treatment, glycemic control was still optimal, and no hypoglycemic episodes were observed. The case report demonstrates the clinical features of ABCC8-associated MODY and the therapeutic potential of a combination of sulfonylurea with SGLT2 inhibitor in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s13300-016-0192-9) contains supplementary material, which is available to authorized users. Springer Healthcare 2016-08-18 2016-09 /pmc/articles/PMC5014798/ /pubmed/27538677 http://dx.doi.org/10.1007/s13300-016-0192-9 Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Case Report Ovsyannikova, Alla K. Rymar, Oksana D. Shakhtshneider, Elena V. Klimontov, Vadim V. Koroleva, Elena A. Myakina, Natalya E. Voevoda, Mikhail I. ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title_full | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title_fullStr | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title_full_unstemmed | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title_short | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective |
title_sort | abcc8-related maturity-onset diabetes of the young (mody12): clinical features and treatment perspective |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014798/ https://www.ncbi.nlm.nih.gov/pubmed/27538677 http://dx.doi.org/10.1007/s13300-016-0192-9 |
work_keys_str_mv | AT ovsyannikovaallak abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT rymaroksanad abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT shakhtshneiderelenav abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT klimontovvadimv abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT korolevaelenaa abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT myakinanatalyae abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective AT voevodamikhaili abcc8relatedmaturityonsetdiabetesoftheyoungmody12clinicalfeaturesandtreatmentperspective |